Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study
Wilbraham, Darren, Berg, Paul H., Tsai, Max, Liffick, Emily, Loo, Li Shen, Doty, Erin Gautier, Sellers, Edward
Published in Journal of clinical pharmacology (01.04.2020)
Published in Journal of clinical pharmacology (01.04.2020)
Get full text
Journal Article
Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials
Shapiro, Robert E., Hochstetler, Helen M., Dennehy, Ellen B., Khanna, Rashna, Doty, Erin Gautier, Berg, Paul H., Starling, Amaal J.
Published in Journal of headache and pain (29.08.2019)
Published in Journal of headache and pain (29.08.2019)
Get full text
Journal Article
The current state of acute treatment for migraine in adults in the United States
Cooper, Wade, Doty, Erin Gautier, Hochstetler, Helen, Hake, Ann, Martin, Vincent
Published in Postgraduate medicine (02.10.2020)
Published in Postgraduate medicine (02.10.2020)
Get full text
Journal Article
Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine
Doty, Erin Gautier, Krege, John H, Jin, Leah, Raskin, Joel, Halker Singh, Rashmi B, Kalidas, Kavita
Published in Cephalalgia (01.10.2019)
Published in Cephalalgia (01.10.2019)
Get full text
Journal Article